The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
RetractedWild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Rathmann, W., & Giani, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2568 · Cited by 1,994
Left Ventricular Remodeling After Myocardial Infarction: Pathophysiology and Therapy
Sutton, M. G. S. J., & Sharpe, N. (2000) · Circulation · doi:10.1161/01.cir.101.25.2981 · Cited by 1,824
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
The inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Initiation and perpetuation of NLRP 3 inflammasome activation and assembly
Elliott, E. I., & Sutterwala, F. S. (2015) · Immunological Reviews · doi:10.1111/imr.12286 · Cited by 821
Cardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734
Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732
Lee, B.-C., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.017 · Cited by 695
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Poulter, N. R., Prabhakaran, D., & Caulfield, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61468-9 · Cited by 672
Mezzaroma, E., Toldo, S., Farkas, D., Seropian, I. M., Van Tassell, B. W., Salloum, F. N., Kannan, H. R., Menna, A. C., Voelkel, N. F., & Abbate, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108586108 · Cited by 629
Heid, M. E., Keyel, P. A., Kamga, C., Shiva, S., Watkins, S. C., & Salter, R. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301490 · Cited by 566
Treating inflammation by blocking interleukin-1 in humans
Dinarello, C. A., & van der Meer, J. W. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.008 · Cited by 549
Sandanger, Ø., Ranheim, T., Vinge, L. E., Bliksøen, M., Alfsnes, K., Finsen, A. V., Dahl, C. P., Askevold, E. T., Florholmen, G., Christensen, G., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt091 · Cited by 524
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Westman, P. C., Lipinski, M. J., Luger, D., Waksman, R., Bonow, R. O., Wu, E., & Epstein, S. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.073 · Cited by 506
Mechanisms of inflammasome activation: recent advances and novel insights
Vanaja, S. K., Rathinam, V. A. K., & Fitzgerald, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.009 · Cited by 499
TXNIP regulates peripheral glucose metabolism in humans
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040158 · Cited by 495
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25930 · Cited by 458
Jung, M., Ma, Y., Iyer, R. P., DeLeon-Pennell, K. Y., Yabluchanskiy, A., Garrett, M. R., & Lindsey, M. L. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0622-5 · Cited by 452
Innate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
The global implications of diabetes and cancer
Shi, Y., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60886-2 · Cited by 424
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock
Mao, K., Chen, S., Chen, M., Ma, Y., Wang, Y., Huang, B., He, Z., Zeng, Y., Hu, Y., Sun, S., et al. (2013) · Cell Research · doi:10.1038/cr.2013.6 · Cited by 395
Self-citationThe NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
van Hout, G. P. J., Bosch, L., Ellenbroek, G. H. J. M., de Haan, J. J., van Solinge, W. W., Cooper, M. A., Arslan, F., de Jager, S. C. A., Robertson, A. A. B., Pasterkamp, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw247 · Cited by 331
Barry, E., Roberts, S., Oke, J., Vijayaraghavan, S., Normansell, R., & Greenhalgh, T. (2017) · BMJ · doi:10.1136/bmj.i6538 · Cited by 330
Role of IL-1β in type 2 diabetes
Dinarello, C. A., Donath, M. Y., & Mandrup-Poulsen, T. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833bf6dc · Cited by 327
Liu, Y., Lian, K., Zhang, L., Wang, R., Yi, F., Gao, C., Xin, C., Zhu, D., Li, Y., Yan, W., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0415-z · Cited by 321
Stanley, T. L., Zanni, M. V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., Khor, V. K., Ahima, R. S., & Grinspoon, S. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1170 · Cited by 321
Böni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J. A., Kerr-Conte, J., Pattou, F., Halban, P. A., Weir, G. C., & Donath, M. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0396 · Cited by 320
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
Stutz, A., Kolbe, C.-C., Stahl, R., Horvath, G. L., Franklin, B. S., van Ray, O., Brinkschulte, R., Geyer, M., Meissner, F., & Latz, E. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160933 · Cited by 317
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Paramel Varghese, G., Folkersen, L., Strawbridge, R. J., Halvorsen, B., Yndestad, A., Ranheim, T., Krohg‐Sørensen, K., Skjelland, M., Espevik, T., Aukrust, P., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003031 · Cited by 306
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension
Rust, P., & Ekmekcioglu, C. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_147 · Cited by 286
Marchetti, C., Chojnacki, J., Toldo, S., Mezzaroma, E., Tranchida, N., Rose, S. W., Federici, M., Van Tassell, B. W., Zhang, S., & Abbate, A. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000053 · Cited by 264
Myocardial remodeling in hypertension
Nadruz, W. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.36 · Cited by 258
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
Menu, P., Pellegrin, M., Aubert, J.-F., Bouzourene, K., Tardivel, A., Mazzolai, L., & Tschopp, J. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.18 · Cited by 251
IL‐1β and IL‐18: inflammatory markers or mediators of hypertension?
Krishnan, S. M., Sobey, C. G., Latz, E., Mansell, A., & Drummond, G. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12876 · Cited by 215
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
Hui, S. T. Y., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z., Sachithanantham, S., Jung, D. Y., Kim, J. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800293105 · Cited by 214
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Takahashi, M. (2014) · International Heart Journal · doi:10.1536/ihj.13-388 · Cited by 199
Cardiac remodeling at the population level—risk factors, screening, and outcomes
Gjesdal, O., Bluemke, D. A., & Lima, J. A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.154 · Cited by 193
NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Zheng, F., Xing, S., Gong, Z., & Xing, Q. (2013) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2013.01.012 · Cited by 190
LOX-1 in Atherosclerosis and Myocardial Ischemia
Pothineni, N. V. K., Karathanasis, S. K., Ding, Z., Arulandu, A., Varughese, K. I., & Mehta, J. L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.010 · Cited by 184
Self-citationSavoye, C., Equine, O., Tricot, O., Nugue, O., Segrestin, B., Sautière, K., Elkohen, M., Pretorian, E. M., Taghipour, K., Philias, A., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.011 · Cited by 183
Ogg1 -Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis
Tumurkhuu, G., Shimada, K., Dagvadorj, J., Crother, T. R., Zhang, W., Luthringer, D., Gottlieb, R. A., Chen, S., & Arditi, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.308362 · Cited by 181
Chen, W., Zhao, M., Zhao, S., Lu, Q., Ni, L., Zou, C., Lu, L., Xu, X., Guan, H., Zheng, Z., et al. (2017) · Inflammation Research · doi:10.1007/s00011-016-1002-6 · Cited by 178
Abderrazak, A., Couchie, D., Mahmood, D. F. D., Elhage, R., Vindis, C., Laffargue, M., Matéo, V., Büchele, B., Ayala, M. R., El Gaafary, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013730 · Cited by 176
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Youm, Y.-H., Adijiang, A., Vandanmagsar, B., Burk, D., Ravussin, A., & Dixit, V. D. (2011) · Endocrinology · doi:10.1210/en.2011-1326 · Cited by 174
Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Koenen, T. B., Stienstra, R., van Tits, L. J., de Graaf, J., Stalenhoef, A. F. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2011) · Diabetes · doi:10.2337/db10-0266 · Cited by 172
Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis
Lu, J., Mitra, S., Wang, X., Khaidakov, M., & Mehta, J. L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3792 · Cited by 166
Self-citationZheng, F. Y., Xing, S., Gong, Z., Mu, W., & Xing, Q. (2014) · Mediators of Inflammation · doi:10.1155/2014/507208 · Cited by 162
The Inflammasome in Myocardial Injury and Cardiac Remodeling
Toldo, S., Mezzaroma, E., Mauro, A. G., Salloum, F., Van Tassell, B. W., & Abbate, A. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5989 · Cited by 160
Wang, Y., Wu, Y., Chen, J., Zhao, S., & Li, H. (2013) · Cardiology · doi:10.1159/000351179 · Cited by 158
Gan, W., Ren, J., Li, T., Lv, S., Li, C., Liu, Z., & Yang, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.001 · Cited by 158
Sterile inflammatory responses mediated by the NLRP3 inflammasome
Cassel, S. L., & Sutterwala, F. S. (2010) · European Journal of Immunology · doi:10.1002/eji.200940207 · Cited by 153
Interleukin-1 beta targeted therapy for type 2 diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903136688 · Cited by 148
LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis
Ding, Z., Liu, S., Wang, X., Dai, Y., Khaidakov, M., Deng, X., Fan, Y., Xiang, D., & Mehta, J. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu114 · Cited by 146
Self-citationInhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy
Perrone, L., Devi, T. S., Hosoya, K.-I., Terasaki, T., & Singh, L. P. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.42 · Cited by 143
P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation
Kuang, P., Liu, L.-S., Wei, D., Lv, Y.-C., Wang, G., Xiong, W., Wang, X., Altaf, A., Wang, L., He, D., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2129 · Cited by 142
Self-citationFeng, H., Gu, J., Gou, F., Huang, W. G., Gao, C., Chen, G., Long, Y., Zhou, X., Yang, M., Liu, S., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6973175 · Cited by 128
Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems
Fujita, T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121258 · Cited by 124
Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?
Clark, A., Jones, L. C., de Koning, E. J. P., HANSEN, B. C., & Matthews, D. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s169 · Cited by 121
Kamari, Y., Shaish, A., Shemesh, S. S., Vax, E., Grosskopf, I., Dotan, S., White, M. R., Voronov, E., Dinarello, C. A., Apte, R. N., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.008 · Cited by 118
Bliksøen, M., Mariero, L. H., Torp, M., Baysa, A., Ytrehus, K., Haugen, F., Seljeflot, I., Vaage, J., Valen, G., & Stensløkken, K. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0553-6 · Cited by 118
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Bruder-Nascimento, T. B., Ferreira, N. S., Zanotto, C. Z., Ramalho, F. N. Z., Pequeno, I. O., Olivon, V. C., Neves, K. B., Alves-Lopes, R., Campos, E., Silva, C. A. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024369 · Cited by 118
Crosstalk between the heart and peripheral organs in heart failure
Jahng, J. W. S., Song, E., & Sweeney, G. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.20 · Cited by 114
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Yajima, N., Takahashi, M., Morimoto, H., Shiba, Y., Takahashi, Y., Masumoto, J., Ise, H., Sagara, J., Nakayama, J., Taniguchi, S., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.746453 · Cited by 104
Role of the SDF-1/CXCR4 System in Myocardial Infarction
Takahashi, M. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-1021 · Cited by 101
Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes
Kim, Y., Wang, W., Okla, M., Kang, I., Moreau, R. F., & Chung, S. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m062828 · Cited by 100
Zhang, W., Tao, A., Lan, T., Cepinskas, G., Kao, R. L. C., Martin, C. M., & Rui, T. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0603-8 · Cited by 98
Su, Q., Qin, D.-N., Wang, F.-X., Ren, J. T., Li, H., Zhang, M., Yang, Q. Z., Miao, Y.-W., Yu, X., Qi, J., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.02.002 · Cited by 93
Sema3A promotes the resolution of cardiac inflammation after myocardial infarction
Rienks, M., Carai, P., Bitsch, N. J. J. E., Schellings, M. W. M., Vanhaverbeke, M., Verjans, J. W. H., Cuijpers, I., Heymans, S. R. B., & Papageorgiou, A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0630-5 · Cited by 88
Qi, J., Yu, X., Shi, X., Gao, H., Yi, Q.-Y., Tan, H., Fan, X.-Y., Zhang, Y., Song, X., Cui, W., et al. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-015-9344-9 · Cited by 76
Protective and pathogenic roles of CD8+ T cells in atherosclerosis
Cochain, C., & Zernecke, A. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0589-7 · Cited by 73
Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure
Kingery, J. R., Hamid, T., Lewis, R. K., Ismahil, M. A., Bansal, S. S., Rokosh, G. D., Townes, T. M., Ildstad, S. T., Jones, S. P., & Prabhu, S. D. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0609-2 · Cited by 73
Role of the Inflammasome in Myocardial Infarction
Takahashi, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.02.002 · Cited by 68
Targeting danger-associated molecular patterns after myocardial infarction
van Hout, G. P. J., Arslan, F., Pasterkamp, G., & Hoefer, I. E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1088005 · Cited by 67
Sharma, A., Jen, R., Kan, B., Sharma, A., Marchant, E. A., Tang, A., Gadawski, I., Senger, C., Skoll, A., Turvey, S. E., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444707 · Cited by 65
Franchi, L., & Núñez, G. (2012) · Science · doi:10.1126/science.1229010 · Cited by 63
Yu, X., Zhang, D., Jia, L., Qi, J., Song, X., Tan, H., Cui, W., Chen, W., Zhu, G., Qin, D.-N., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.023 · Cited by 63
Qi, J., Zhao, X.-F., Yu, X., Yi, Q.-Y., Shi, X., Tan, H., Fan, X.-Y., Gao, H., Li-ying, Y., Feng, Z., et al. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-015-9338-7 · Cited by 58
van Greevenbroek, M. M. J., Vermeulen, V. M. M.-J., Feskens, E. J. M., Evelo, C. T., Kruijshoop, M., Hoebee, B., Kallen, C., & de Bruin, T. W. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02109.x · Cited by 56
Gomperts, E. D., Belcher, J. D., Otterbein, L. E., Coates, T. D., Wood, J. C., Skolnick, B. E., Levy, H. A., & Vercellotti, G. M. (2017) · American Journal of Hematology · doi:10.1002/ajh.24750 · Cited by 54
LOX-1 and Angiotensin Receptors, and Their Interplay
Wang, X., Phillips, M. I., & Mehta, J. L. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6331-7 · Cited by 47
Self-citation慢性腎不全の一般的な日本人集団における血清ナトリウム利尿ペプチド(BNP)濃度への過剰塩分摂取の影響度
Tamabuchi, T., Watanabe, T., Tsuneo, K., et al. (2010) · Circulation · Cited by 47
Could NLRP3–Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?
Bullón, P., Cano‐García, F. J., Alcocer‐Gómez, E., Varela‐López, A., Román-Malo, L., Ruiz-Salmeron, R. J., Quiles, J. L., Navarro-Pando, J. M., Battino, M. A., Ruı́z-Cabello, J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6970 · Cited by 41
Tomczyk, M., Kraszewska, I., Szade, K., Bukowska-Straková, K., Meloni, M., Józkowicz, A., Dulak, J., & Jaźwa, A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0629-y · Cited by 41
Mechanisms of Salt-Sensitive Hypertension
Luzardo, L., Noboa, O. A., & Boggia, J. G. (2015) · Current Hypertension Reviews · doi:10.2174/1573402111666150530204136 · Cited by 38
Inflammasome and Atherogenesis
Lu, X., & Kakkar, V. V. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990586 · Cited by 26
Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction
Li, L., Wang, X., Chen, W., Qi, H., Jiang, D.-S., Huang, L., Huang, F., Wang, L., Li, H., & Chen, X. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0515-4 · Cited by 22
Self-citationInoue, Y., Yasuda, Y., & Takahashi, M. (2013) · Hepatology · doi:10.1002/hep.26480 · Cited by 11
Cited by
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 604
ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways
de Almeida, A. J. P. O., de Oliveira, J. C. P. L., da Silva Pontes, L. V., de Souza Júnior, J. F., Gonçalves, T. A. F., Dantas, S. H., de Almeida Feitosa, M. S., Silva, A. O., & de Medeiros, I. A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1225578 · Cited by 474
Targeting the NLRP3 Inflammasome in Severe COVID-19
Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 405
Li, R., Xin, T., Li, D., Wang, C., Zhu, H., & Zhou, H. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.011 · Cited by 352
Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia–reperfusion injury
Wang, J., & Zhou, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.03.004 · Cited by 323
Metadata
- Authors
- Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X.
- Venue
- Basic Research in Cardiology
- Published
- 2017-12-09
- Volume
- 113
- Issue
- 1
- Pages
- 5-5
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- OpenAlex
- W2773489190
- Cited by
- 258
- References
- 115
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.